Regeneron Pharmaceuticals, Inc.
http://www.regeneron.com
Already a Biomedtracker subscriber?
You have access to the full company record through your subscription
Want to become a subscriber?
Subscribers get more company details, updates, company financials and company products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Regeneron Pharmaceuticals, Inc.
Stockwatch: Will Biogen Keep Digging After Tough Quarter?
Biogen’s poor third-quarter results cannot be blamed solely on the pandemic. Pipeline attrition and underperformance in most franchises pushes all the risk onto a dubious throw of the regulatory dice.
Publisher's Spotlight: Clinical And Research Excellence Honored At The Citeline Awards
Informa Pharma Intelligence congratulates the winners of the fifth annual awards.
Publisher's Spotlight: Clinical And Research Excellence Honored At The Citeline Awards
Informa Pharma Intelligence congratulates the winners of the fifth annual awards.
Coronavirus Update: Gilead's Veklury Gets Full FDA Approval, Roche Partners With Atea
Gilead's remdesivir is first drug fully approved by FDA to treat COVID-19. Roche and Atea team up on an investigational direct acting antiviral while Moderna reaches the 30,000-patient enrollment target for its Phase III COVE study of the company's investigational mRNA vaccine.
Company Information
- Industry
- Pharmaceuticals
-
Biotechnology
- Drug Discovery Tools
- Gene Therapy, Cell Therapy
-
Large Molecule
- Antibodies
- Other Names / Subsidiaries
-
- Regeneron Genetics Center LLC (RGC)